AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
BRAIN-DERIVED NEUROTROPHIC FACTOR IN AMYOTROPHIC-LATERAL-SCLEROSIS - A FAILED DRUG OR A FAILED TRIAL
Authors: CEDARBAUM JM STAMBLER N BROOKS BR BRADLEY W
Citation: Jm. Cedarbaum et al., BRAIN-DERIVED NEUROTROPHIC FACTOR IN AMYOTROPHIC-LATERAL-SCLEROSIS - A FAILED DRUG OR A FAILED TRIAL, Annals of neurology, 44(3), 1998, pp. 255-255
PHYSIOLOGICAL CHARACTERIZATION OF TAXOL-INDUCED LARGE FIBER SENSORY NEUROPATHY IN THE RAT
Authors: CLIFFER KD SIUCIAK JA CARSON SR RADLEY HE PARK JS LEWIS DR ZLOTCHENKO E NGUYEN T GARCIA K TONRA JR STAMBLER N CEDARBAUM JM BODINE SC LINDSAY RM DISTEFANO PS
Citation: Kd. Cliffer et al., PHYSIOLOGICAL CHARACTERIZATION OF TAXOL-INDUCED LARGE FIBER SENSORY NEUROPATHY IN THE RAT, Annals of neurology, 43(1), 1998, pp. 46-55
PROGNOSTIC INDICATORS OF SURVIVAL IN ALS
Authors: STAMBLER N CHARATAN M CEDARBAUM JM
Citation: N. Stambler et al., PROGNOSTIC INDICATORS OF SURVIVAL IN ALS, Neurology, 50(1), 1998, pp. 66-72
ENDOGENOUS NGF AND CNTF LEVELS IN HUMAN PERIPHERAL-NERVE INJURY
Authors: ANAND P TERENGHI G BIRCH R WELLMER A CEDARBAUM JM LINDSAY RM WILLIAMSCHESTNUT RE SINICROPI DV
Citation: P. Anand et al., ENDOGENOUS NGF AND CNTF LEVELS IN HUMAN PERIPHERAL-NERVE INJURY, NeuroReport, 8(8), 1997, pp. 1935-1938
STABILITY OF LEVODOPA CARBIDOPA SOLUTIONS
Authors: CEDARBAUM JM
Citation: Jm. Cedarbaum, STABILITY OF LEVODOPA CARBIDOPA SOLUTIONS, Movement disorders, 12(4), 1997, pp. 625-625
INTRATHECAL CILIARY NEUROTROPHIC FACTOR DELIVERY FOR TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS (PHASE-I TRIAL)
Authors: PENN RD KROIN JS YORK MM CEDARBAUM JM
Citation: Rd. Penn et al., INTRATHECAL CILIARY NEUROTROPHIC FACTOR DELIVERY FOR TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS (PHASE-I TRIAL), Neurosurgery, 40(1), 1997, pp. 94-99
PERFORMANCE OF THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) IN MULTICENTER CLINICAL-TRIALS
Authors: CEDARBAUM JM STAMBLER N
Citation: Jm. Cedarbaum et N. Stambler, PERFORMANCE OF THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE (ALSFRS) IN MULTICENTER CLINICAL-TRIALS, Journal of the neurological sciences, 152, 1997, pp. 1-9
PHARMACOKINETICS AND PHARMACODYNAMICS OF RHCNTF IN RODENTS
Authors: CEDARBAUM JM DISTEFANO PS LAKINGS DB LINDSAY RM
Citation: Jm. Cedarbaum et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RHCNTF IN RODENTS, Annals of neurology, 39(4), 1996, pp. 552-553
A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: LOTZ B BROOKS B SANJAK M WEASLER C ROELKE K PARNELL J NEVILLE H RINGEL S BRINKMANN J SINGH K BURNS D PESTRONK A LOPATE G FLORENCE J BLUME G ELIOTT J MITSUMOTO H LEVIN K SZIRONY K CALDWELL M BOSCH P SMITH B VERHEIJDE J CARR S ENGEL WK VELAZQUEZ L MILLER J GRAVES M SEPULVEDA L GARCIA S SMITH R LICHT J GILLIE E SILVERMAN L OLNEY R YUEN E MELNICK M MASS J BRADLEY W SHARMA K HURTAK L MAYOR L OLANOW CW HAUSER R MALAPIRA T OLANOW E HOPKINS L WEISSMAN J PIANTA T POLAK M SIDDIQUE T SUFIT R CASEY P ROOS R SALAZARGRUESO E RICHMAN J KASARSKIS E ENGLISH T BOTTOMS B SHEFNER J LOGIGIAN E ODAKA B CORWIN C KUNCL R ROTHSTEIN J CLAWSON L CHAUDHRY V CORNBLATH D CORSE A BROMBERG M WALD J FORSHEW D LITCHY W WINDEBANK A BUSS J CAMPION J DAUBE JR SUBRAMONY SH VEDANARAYANAN V WEAVER R CROSSWHITE T KULA R ANSELMI G RIHA T SORRENTINO C HOLMLUND T WARNER C CAMANN M MILLARD C DONNENFELD H KLEINMAN A SIVAK M ALAMPUR U HOEHL J BRATTON J JUBELT B CARY G BARRY J DRUCKER J SAMAHA F SAMS L CLARKE A SCHWIEDERMAN D MENDELL J SAHENK Z KING W DOWNING K BIRD S SCHERER S BEALE J PFOHL D HEIMANPATTERSON T SHY M SUH Y GIULIANI M LACOMIS D DECESARE S HOLBACH S FENICHEL G HOWARD J ROBISON J TANDAN R PEET P CUSIMANO S KRUSINSKI P HILLEL A SUMI M VEALE M KONIKOW N BROOKE M CWIK V BURDEN N BOYD C DASILVA B STRONG M ROWE A FINDLATER K CASHMAN N ANTEL J FINCH L BRISSETTE J FISHER MR COOK T DEMETS D BECHHOFER R YOSHIHARA D WITTES J MCKHANN G ELLENBERG J GRIGGS RC LOWENTHAL D LEVINE R STAMBLER N CHARATAN M CEDARBAUM JM
Citation: B. Lotz et al., A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS, Neurology, 46(5), 1996, pp. 1244-1249
NEUROTROPHIN-3 AMELIORATES CIS-PLATINUM-INDUCED NEUROPATHY
Authors: CLIFFER K DISTEFANO PS ANDREWS L CURTIS R STAMBLER N LINDSAY RM CEDARBAUM JM
Citation: K. Cliffer et al., NEUROTROPHIN-3 AMELIORATES CIS-PLATINUM-INDUCED NEUROPATHY, Neurology, 46(2), 1996, pp. 3034-3034
NEUROTROPHIN-3 INCREASES SYMPATHETIC NEURON TYROSINE-HYDROXYLASE ACTIVITY WITHOUT PRODUCING HYPERALGESIA
Authors: WONG V SIUCIAK JA STAMBLER N LINDSAY RM CEDARBAUM JM DISTEFANO PS
Citation: V. Wong et al., NEUROTROPHIN-3 INCREASES SYMPATHETIC NEURON TYROSINE-HYDROXYLASE ACTIVITY WITHOUT PRODUCING HYPERALGESIA, Neurology, 46(2), 1996, pp. 3035-3035
THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: BROOKS BR SANJAK M RINGEL S ENGLAND J BRINKMANN J PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K WITTES J CHARATAN M STAMBLER N CEDARBAUM JM
Citation: Br. Brooks et al., THE AMYOTROPHIC-LATERAL-SCLEROSIS FUNCTIONAL RATING-SCALE - ASSESSMENT OF ACTIVITIES OF DAILY LIVING IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Archives of neurology, 53(2), 1996, pp. 141-147
REGIONAL CHANGES OF CILIARY NEUROTROPHIC FACTOR AND NERVE GROWTH-FACTOR LEVELS IN POST-MORTEM SPINAL-CORD AND CEREBRAL-CORTEX FROM PATIENTSWITH MOTOR DISEASE
Authors: ANAND P PARRETT A MARTIN J ZEMAN S FOLEY P SWASH M LEIGH PN CEDARBAUM JM LINDSAY RM WILLIAMSCHESTNUT RE SINICROPI DV
Citation: P. Anand et al., REGIONAL CHANGES OF CILIARY NEUROTROPHIC FACTOR AND NERVE GROWTH-FACTOR LEVELS IN POST-MORTEM SPINAL-CORD AND CEREBRAL-CORTEX FROM PATIENTSWITH MOTOR DISEASE, Nature medicine, 1(2), 1995, pp. 168-172
EFFECTS OF BRAIN-DERIVED NEUROTROPHIC FACTOR ON MOTOR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE
Authors: IKEDA K KLINKOSZ B GREENE T CEDARBAUM JM WONG V LINDSAY RM MITSUMOTO H
Citation: K. Ikeda et al., EFFECTS OF BRAIN-DERIVED NEUROTROPHIC FACTOR ON MOTOR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE, Annals of neurology, 37(4), 1995, pp. 505-511
HISTOMETRIC EFFECTS OF CILIARY NEUROTROPHIC FACTOR IN WOBBLER MOUSE MOTOR-NEURON DISEASE
Authors: IKEDA K WONG V HOLMLUND TH GREENE T CEDARBAUM JM LINDSAY RM MITSUMOTO H
Citation: K. Ikeda et al., HISTOMETRIC EFFECTS OF CILIARY NEUROTROPHIC FACTOR IN WOBBLER MOUSE MOTOR-NEURON DISEASE, Annals of neurology, 37(1), 1995, pp. 47-54
THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE
Authors: CEDARBAUM JM CHAPMAN C CHARATAN M STAMBLER N ANDREWS L ZHAN C RADKA S MORRISEY D LAKINGS D BROOKS BR SANJAK M PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K BITTLE L RINGEL S NEVILLE H BRINKMANN J
Citation: Jm. Cedarbaum et al., THE PHARMACOKINETICS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMANCILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS - RELATION TO PARAMETERS OF THE ACUTE-PHASE RESPONSE, Clinical neuropharmacology, 18(6), 1995, pp. 500-514
A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: CEDARBAUM JM CHAPMAN C CHARATAN M STAMBLER N ANDREWS L ZHAN C RADKA S MORRISEY D LAKINGS D BROOKS BR SANJAK M PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K BITTLE L NEVILLE H RINGEL S BRINKMANN J WITTES J
Citation: Jm. Cedarbaum et al., A PHASE-I STUDY OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Clinical neuropharmacology, 18(6), 1995, pp. 515-532
THE EFFECTS OF CILIARY NEUROTROPHIC FACTOR ON MOTOR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE
Authors: MITSUMOTO H IKEDA K HOLMLUND T GREENE T CEDARBAUM JM WONG V LINDSAY RM
Citation: H. Mitsumoto et al., THE EFFECTS OF CILIARY NEUROTROPHIC FACTOR ON MOTOR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE, Annals of neurology, 36(2), 1994, pp. 142-148
ARREST OF MOTOR-NEURON DISEASE IN WOBBLER MICE COTREATED WITH CNTF AND BDNF
Authors: MITSUMOTO H IKEDA K KLINKOSZ B CEDARBAUM JM WONG V LINDSAY RM
Citation: H. Mitsumoto et al., ARREST OF MOTOR-NEURON DISEASE IN WOBBLER MICE COTREATED WITH CNTF AND BDNF, Science, 265(5175), 1994, pp. 1107-1110
ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
Authors: BROOKS BR SANJAK M NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K WITTES J BRITTAIN E STAMBLER N CHARATAN M CHAPMAN C CEDARBAUM JM
Citation: Br. Brooks et al., ANALYZING THE EFFECT OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR(RHCNTF) ON MUSCLE STRENGTH IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Neurology, 44(4), 1994, pp. 10000166-10000166
CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS
Authors: CEDARBAUM JM WITTES J BRITTAIN E BROOKS BR SANJAK M NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J MITSUMOTO H SZIRONY K STAMBLER N CHARATAN M CHAPMAN C
Citation: Jm. Cedarbaum et al., CORRELATION BETWEEN RATES OF CHANGE IN FUNCTIONAL RATING-SCALES AND MUSCLE STRENGTH MEASURES IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS, Neurology, 44(4), 1994, pp. 10000256-10000257
ADMINISTRATION OF THE NEW COMT INHIBITOR OR-611 INCREASES STRIATAL UPTAKE OF FLUORODOPA
Authors: GUTTMAN M LEGER G RECHES A EVANS A KUWABARA H CEDARBAUM JM GJEDDE A
Citation: M. Guttman et al., ADMINISTRATION OF THE NEW COMT INHIBITOR OR-611 INCREASES STRIATAL UPTAKE OF FLUORODOPA, Movement disorders, 8(3), 1993, pp. 298-304
BRAIN-DERIVED NEUROTROPHIC FACTOR ATTENUATES NEUROMUSCULAR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE
Authors: IKEDA K MITSUMOTO H CEDARBAUM JM WONG V LINDSAY RM
Citation: K. Ikeda et al., BRAIN-DERIVED NEUROTROPHIC FACTOR ATTENUATES NEUROMUSCULAR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE, Annals of neurology, 34(2), 1993, pp. 304-304
THE EFFECT OF L-DOPA INFUSIONS WITH AND WITHOUT PHENYLALANINE CHALLENGES IN PARKINSONIAN-PATIENTS - PLASMA AND VENTRICULAR CSF L-DOPA LEVELS AND CLINICAL-RESPONSES
Authors: WOODWARD WR OLANOW CW BECKNER RM HAUSER RA GAUGER LL CEDARBAUM JM NUTT JG
Citation: Wr. Woodward et al., THE EFFECT OF L-DOPA INFUSIONS WITH AND WITHOUT PHENYLALANINE CHALLENGES IN PARKINSONIAN-PATIENTS - PLASMA AND VENTRICULAR CSF L-DOPA LEVELS AND CLINICAL-RESPONSES, Neurology, 43(9), 1993, pp. 1704-1708
MORPHOLOGICAL-CHANGES CORRELATE WITH FUNCTIONAL IMPROVEMENT FOLLOWINGCILIARY NEUROTROPHIC FACTOR (CNTF) TREATMENT OF MOTOR-NEURON DISEASE IN THE WOBBLER MOUSE
Authors: IKEDA K MITSUMOTO H WONG V CEDARBAUM JM LINDSAY RM
Citation: K. Ikeda et al., MORPHOLOGICAL-CHANGES CORRELATE WITH FUNCTIONAL IMPROVEMENT FOLLOWINGCILIARY NEUROTROPHIC FACTOR (CNTF) TREATMENT OF MOTOR-NEURON DISEASE IN THE WOBBLER MOUSE, Neurology, 43(4), 1993, pp. 321-321
Risultati: 1-25 | 26-29